Skip to main content
SpringerLink
Log in

Membrane Transport in Hepatic Clearance of Drugs II: Zonal Distribution Patterns of Concentration-Dependent Transport and Elimination Processes

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Purpose. The objective of the present simulation study was to investigate the effects of hepatic zonal heterogeneity of membrane transporter proteins and intrinsic elimination activities on hepatic clearance (CL) and drug concentration gradient profiles in the sinusoidal blood and hepatocytes.

Methods. The model used in the simulations assumes an apparent unidirectional carrier-mediated transport and a bidirectional diffusion of substrates in the hepatic sinusoidal membrane as well as a nonlinear intrinsic elimination. Three different distribution patterns of the transporter and the metabolizing enzyme along the sinusoidal flow path were used for the simulations. The effects of changes in the Michaelis-Menten parameters for those nonlinear processes, and in the unbound fractions of the drug in blood and tissue components were investigated.

Results. Significant differences in CL occurred when the distribution patterns of the transporter and/or the metabolizing enzyme activities were altered under nonlinear conditions. The highest CL values were observed when the transporter and the metabolizing enzyme had similar distribution patterns within the liver acinus, while opposite distribution patterns produced the lowest CL values. Tissue concentration profiles were significantly affected by the distribution patterns of the transporter, but the changes in blood concentration profiles were relatively small. Altering protein binding in blood produced significant changes in CL, and blood and tissue concentration gradients, while altering protein binding in tissue affected only drug accumulation patterns within hepatocytes, regardless of the distribution patterns of the transporter or the metabolizing enzyme.

Conclusions. The present simulations demonstrate that hepatic zonal heterogeneities in the transporter and the metabolizing enzyme activities can significantly influence hepatic clearance and/or drug concentration gradient profiles in the sinusoidal blood and hepatocytes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. J. J. Gumucio. Hepatology 9(1):154–160 (1989).

    PubMed  Google Scholar 

  2. N. Katz and K. Jungermann. In “Hepatic transport and bile secretion: physiology and pathology” (N. Tavoloni and P. D. Berk, eds), Raven Press Ltd., New York, pp. 55–70 (1993).

    Google Scholar 

  3. K. Jungermann and N. Katz. Physiol. Rev. 69:708–764 (1989).

    PubMed  Google Scholar 

  4. B. Quistorff. Essays Biochem. 25:83–136 (1990).

    PubMed  Google Scholar 

  5. J. J. Gumucio and E. E. Guibert. In “Hepatic transport and bile secretion: physiology and pathology” (N. Tavoloni and P. D. Berk, eds), Raven Press Ltd., New York, pp. 71–82 (1993).

    Google Scholar 

  6. G. M. M. Groothuis and D. K. F. Meijer. Enzyme 46:94–138 (1992).

    PubMed  Google Scholar 

  7. H. J. Burger, R. Gebhardt, C. Mayer, and D. Mecke. Hepatology. 9(1):22–28 (1989).

    PubMed  Google Scholar 

  8. G. M. M. Groothuis, K. P. T. Keulemans, M. J. Hardonk, and D. K. F. Meijer. Biochem. Pharmacol. 32(20):3069–3078 (1983).

    PubMed  Google Scholar 

  9. G. M. M. Groothuis, J. G. Weitering, K. P. T. Keulemans, M. J. Hardonk, D. Mulder, and D. K. F. Meijer. Naunyn-Schmiedeberg's Arch. Pharmacol. 322:310–318 (1983).

    Google Scholar 

  10. H. Saiki, E. T. Chan, E. Wong, W. Yamamuro, M. Ookhtens, and N. Kaplowitz. J. Biol. Chem. 267:192–196 (1992).

    PubMed  Google Scholar 

  11. I. Braakman, G. M. M. Groothuis, and D. K. F. Meijer. Hepatology. 7(5):849–855 (1987).

    PubMed  Google Scholar 

  12. J. J. Gumucio, D. L. Miller, M. D. Krauss, and C. C. Zanolli. Gastroenterology. 80:639–646 (1981).

    PubMed  Google Scholar 

  13. P. V. D. Sluijs, I. Braakman, D. K. F. Meijer, and G. M. M. Groothuis. Hepatology. 8(6):1521–1529 (1988).

    PubMed  Google Scholar 

  14. C. A. Goresky, G. G. Bach, and C. P. Rose. Am. J. Physiol. 244:G215–G232 (1983).

    PubMed  Google Scholar 

  15. H. Sato, Y. Sugiyama, S. Miyauchi, Y. Sawada, T. Iga, and M. Hanano. J. Pharm. Sci. 75(1):3–8 (1986).

    PubMed  Google Scholar 

  16. M. E. Morris and K. S. Pang. J. Pharmacokin. Biopharm. 15(5):473–496 (1987).

    Google Scholar 

  17. M. E. Morris, V. Yuen, and K. S. Pang. J. Pharmacokin. Biopharm. 16(6):633–656 (1988).

    Google Scholar 

  18. D. K. F. Meijer, W. E. M. Mol, M. Muller, and G. Kurz. J. Pharmacokin. Biopharm. 18:35–70 (1990).

    Google Scholar 

  19. R. H. Moseley, S. M. Jarose, and P. Permoad. Am. J. Physiol. 263:G775–G785 (1992).

    PubMed  Google Scholar 

  20. S. Keiding, S. Johansen, K. Winkler, K. Tønnesen, and N. Tygstrup. Am. J. Physiol. 230(5):1302–1313 (1976).

    PubMed  Google Scholar 

  21. J. Reichen and G. Paumgartner. Gastroenterology. 68:132–136 (1975).

    PubMed  Google Scholar 

  22. Y. Kwon and M. E. Morris. Pharm. Res. (companion article).

  23. R. B. Hornbeck. In Numerical Methods, Quantum Publishers, Inc., New York, 1975, pp. 185–226.

    Google Scholar 

  24. M. Yamazaki, H. Suzuki, and Y. Sugiyami. Pharm. Res. 13:497–513 (1996).

    Article  PubMed  Google Scholar 

  25. K. S. Pang and R. N. Stillwell. J. Pharmacokin. Biopharm. 11:451–468 (1983).

    Google Scholar 

  26. I. A. M. de Lannoy and K. S. Pang. Drug. Metab. Dispos. 14:513–520 (1986).

    PubMed  Google Scholar 

  27. I. A. M. DeLannoy and K. S. Pang. Drug Metab. Dispos. 15(1):51–58 (1987).

    PubMed  Google Scholar 

  28. C. A. Goresky, G. G. Bach, and B. E. Nadeau. J. Clin. Invest. 52:975–990 (1973).

    PubMed  Google Scholar 

  29. P. L. Gumucio, J. J. Gumucio, J. A. P. Wilson, C. Cutter, M. Krauss, R. Caldwell, and E. Chen. Am. J. Physiol. 246:G86–G95 (1984).

    PubMed  Google Scholar 

  30. X. Xu, P. Selick, and K. S. Pang. J. Pharmacokin. Biopharm. 21:43–74 (1993).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmaceutics, School of Pharmacy, State University of New York at Buffalo, Amherst, New York, 14260

    Younggil Kwon & Marilyn E. Morris

  2. Drug Metabolism Department, Central Research Division, Pfizer Inc., Groton, Connecticut, 06340

    Younggil Kwon

Authors
  1. Younggil Kwon
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marilyn E. Morris
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kwon, Y., Morris, M.E. Membrane Transport in Hepatic Clearance of Drugs II: Zonal Distribution Patterns of Concentration-Dependent Transport and Elimination Processes. Pharm Res 14, 780–785 (1997). https://doi.org/10.1023/A:1012158607766

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1012158607766

Search

Navigation